In a continuance of its support for COVID-19 test development, the US Food and Drug Administration has granted emergency use authorization to several new tests for over-the-counter (OTC) sale.
In addition, the FDA has granted authorization to one serial screening test for use in a point-of-care setting without a prescription, and a point-of-care test that requires a prescription.